Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CyberLiver
London, United Kingdom
- Ownership
- Private
- Development stage
- Other
01
Overview
CyberLiver has developed prescription digital therapeutics including CirrhoCare for decompensated cirrhosis and AlcoChange for alcohol-related liver disease. Clinical studies reported for CirrhoCare in 40 patients showed a 38% reduction in hospital readmissions, 80% reduction in day-hospital ascites drains, and 69% reduction in ICU length of stay, with improved CLIF-C-AD and MELD scores and 85% patient engagement.[2] A 60‑patient AlcoChange study showed a 28% reduction in hospital readmissions, 63% reduction in alcohol consumption, and 63% patient engagement.[2] A larger NIHR-funded randomized trial of CirrhoCare versus standard care is ongoing across multiple UK hospitals.[7]
- Therapeutic areas
- PsychiatryGastroenterology
- Modalities
- Non-pharmacological therapyDeviceSoftware-driven interventionDigital therapeutic
- Industry
- Digital Health Medical Devices
02
Partnerships
National Health Service (NHS) sites in the UK using/assessing CirrhoCare[2][7]NIHR-funded multicentre UK trial collaboration[7]Collaborations via P4 Precision Medicine Programme (UCLPartners) and Yorkshire & Humber AHSN programmes[3]
Beyond the preview
Go deeper on CyberLiver.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on CyberLiver.